Emerging leader in drug device combination products selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Framingham, MA, December 18, 2006 – clinivation, Inc. announced today that Biocompatibles International plc (LSE: BII) has selected clinivation WorldView™ Online Regulatory Intelligence solution.
“We are pleased that Biocompatibles has selected clinivation WorldView as their source for worldwide regulatory intelligence and procedures,” remarked Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions, “With information on >99% of the world markets, Biocompatibles will be able to stay current on ever-changing regulations,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global™ enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About Biocompatibles International PLC
Biocompatibles International plc is the medical technology company focused on drug device Combination Products principally for use in oncology.
For further information, visit www.biocompatibles.com
